192 related articles for article (PubMed ID: 37300986)
1. Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.
Stewart SF; Slodkowska-Barabasz J; McGeagh L; Moon Z; Brett J; Wells M; Brown MC; Turner M; Horne R; Fenlon D; Rehman F; Cain H; Donnelly P; Harmer V; Turner L; Rose J; Sharp L; Watson E;
Breast; 2023 Aug; 70():32-40. PubMed ID: 37300986
[TBL] [Abstract][Full Text] [Related]
2. Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.
Green SMC; French DP; Graham CD; Hall LH; Rousseau N; Foy R; Clark J; Parbutt C; Raine E; Gardner B; Velikova G; Moore SJL; Buxton J; ; Smith SG
BMC Health Serv Res; 2022 Aug; 22(1):1081. PubMed ID: 36002831
[TBL] [Abstract][Full Text] [Related]
3. Codevelopment of a Text Messaging Intervention to Support Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: Mixed Methods Approach.
Green SMC; French DP; Hall LH; Bartlett YK; Rousseau N; Raine E; Parbutt C; Gardner B; ; Smith SG
J Med Internet Res; 2023 May; 25():e38073. PubMed ID: 37223964
[TBL] [Abstract][Full Text] [Related]
4. Women with breast cancer's perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study.
Gagné M; Lauzier S; Lemay M; Loiselle CG; Provencher L; Simard C; Guillaumie L
Support Care Cancer; 2022 Jun; 30(6):4759-4768. PubMed ID: 35133477
[TBL] [Abstract][Full Text] [Related]
5. THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer.
Paladino AJ; Anderson JN; Krukowski RA; Waters T; Kocak M; Graff C; Blue R; Jones TN; Buzaglo J; Vidal G; Schwartzberg L; Graetz I
BMC Health Serv Res; 2019 Dec; 19(1):977. PubMed ID: 31856812
[TBL] [Abstract][Full Text] [Related]
6. Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach.
Labonté M; Guillaumie L; Dionne A; Dorval M; Nabi H; Lemieux J; Provencher L; Lauzier S
Res Social Adm Pharm; 2020 Dec; 16(12):1724-1736. PubMed ID: 32205070
[TBL] [Abstract][Full Text] [Related]
7. A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.
Jacobs JM; Post K; Massad K; Horick NK; Walsh EA; Cohn J; Rapoport CS; Clara AJ; Antoni MH; Safren SA; Partridge AH; Peppercorn JM; Park ER; Temel JS; Greer JA
Cancer; 2022 Oct; 128(19):3541-3551. PubMed ID: 35924869
[TBL] [Abstract][Full Text] [Related]
8. A pilot randomised controlled trial of acceptance and commitment therapy for medication decision-making and quality of life in women with breast cancer: The ACTION trial.
Graham CD; Ellison R; Hall LH; Clark J; McNaught E; Green SMC; Wilkes H; Robson G; Lorentz I; Holmes L; Bould N; Hartley S; Naik J; Buckley S; Hirst C; Hartup S; Foy R; Neal RD; Velikova G; Farrin A; Collinson M; Smith SG
Psychooncology; 2024 May; 33(5):e6349. PubMed ID: 38752788
[TBL] [Abstract][Full Text] [Related]
9. THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care.
Anderson JN; Krukowski RA; Paladino AJ; Graff JC; Schwartzberg L; Curry AN; Vidal GA; Jones TN; Waters TM; Graetz I
J Hosp Manag Health Policy; 2021 Mar; 5():. PubMed ID: 34308256
[TBL] [Abstract][Full Text] [Related]
10. Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial.
Green SMC; Hall LH; Rousseau N; French DP; Graham CD; Collinson M; Mason E; Wilkes H; Howdon D; Foy R; Walwyn R; Clark J; Parbutt C; Raine E; Ellison R; Buxton J; Moore SJL; Velikova G; Farrin A; Smith SG
NIHR Open Res; 2023; 3():3. PubMed ID: 37881449
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Pilot Trial of a Low-Touch Remotely-Delivered Values Intervention to Promote Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors.
Arch JJ; Crespi CM; Levin ME; Genung SR; Nealis M; Mitchell JL; Bright EE; Albright K; Magidson JF; Stanton AL
Ann Behav Med; 2022 Aug; 56(8):856-871. PubMed ID: 35323853
[TBL] [Abstract][Full Text] [Related]
12. Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial.
Smith SG; Green SMC; Ellison R; Foy R; Graham CD; Mason E; French DP; Hall LH; Wilkes H; McNaught E; Raine E; Walwyn R; Howdon D; Clark J; Rousseau N; Buxton J; Moore SJL; Parbutt C; Velikova G; Farrin A; Collinson M
BMJ Open; 2023 Feb; 13(2):e069971. PubMed ID: 36737093
[TBL] [Abstract][Full Text] [Related]
13. Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach.
Janssen AM; Dam J; Prins J; Buffart LM; de Bruin M
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13721. PubMed ID: 36263723
[TBL] [Abstract][Full Text] [Related]
14. The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy.
Jiang H; Dong Y; Zong W; Zhang XJ; Xu H; Jin F
BMC Womens Health; 2022 Apr; 22(1):135. PubMed ID: 35477451
[TBL] [Abstract][Full Text] [Related]
15. Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.
Jacobs JM; Walsh EA; Rapoport CS; Antoni MH; Park ER; Post K; Comander A; Peppercorn J; Safren SA; Temel JS; Greer JA
J Clin Psychol Med Settings; 2021 Sep; 28(3):603-618. PubMed ID: 33219901
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Lambert LK; Balneaves LG; Howard AF; Gotay CC
Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
[TBL] [Abstract][Full Text] [Related]
17. Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment.
Green SMC; Hall LH; French DP; Rousseau N; Parbutt C; Walwyn R; Smith SG
Ann Behav Med; 2023 Oct; 57(11):988-1000. PubMed ID: 37494669
[TBL] [Abstract][Full Text] [Related]
18. Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer.
Brett J; Boulton M; Watson E
Patient Prefer Adherence; 2018; 12():2639-2647. PubMed ID: 30587936
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
Cavazza M; Banks H; Ercolanoni M; Cukaj G; Bianchi G; Capri G; Longo F
Breast Cancer Res Treat; 2020 Aug; 183(1):189-199. PubMed ID: 32591986
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]